For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study ...

For two decades, I had to douse my eyes with artificial tears to get through the day. Then I decided to see if I could shop ...

Hyaluronic acid is another favorite, as it helps retain moisture and promotes increased healing. And for the skincare-ingredient nerds, ectoin is one to watch—it's anti-inflammatory, hydrating, and ...

If you want to "wow" your eyelashes, you may be tempted to get extensions, though risks are involved, say experts.

If you experience chronic dry, itchy and red skin, you may be one of the millions of Americans with eczema. The National Eczema Association reports that an estimated 10% of the world ...

New understanding of a receptor key to allergic responses and anaphylaxis in conditions like asthma could offer a new treatment target for sufferers of a variety of conditions. This the promise of ...

Have itchy eyes? You may have developed eyelid eczema, which affects many people with eczema. Here are three signs that you have it.

Apogee Therapeutics’ anti-IL-13 antibody has been tied to a 71% reduction in eczema severity after 16 weeks, hitting the main goal of a phase 2 trial.

On June 24, Nektar Therapeutics announced positive results from its mid-stage REZOLVE-AD study for rezpegaldesleukin, which is an eczema treatment.

Nektar Therapeutics (NASDAQ:NKTR) is one of the best hot stocks to buy according to Wall Street analysts. On June 24, Nektar Therapeutics announced positive results from its mid-stage REZOLVE-AD ...

Rezpegaldesleukin (Rezpeg) shows fast, effective eczema relief in Phase 2 trial with fewer side effects than other treatments, offering hope for moderate-to-severe cases.